Investor Update

Basel, 29 January 2013

New Drug Application Filed for Antibody-Drug Conjugate

Trastuzumab Emtansine for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.